Drug Enforcement D-0235-2024

Presence of Particulate Matter; identified as glass

Status

Ongoing

Classification

Class I

Report Date

January 24, 2024

Termination Date

—

Product Information

Product description
Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake FOrest, IL 60045, NDC 0409-4911-11 (carton), 0409-4911-34 (case).
Product quantity
24400 Cartons
Reason for recall
Presence of Particulate Matter; identified as glass
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA and Puerto Rico.

Location & Firm

Recalling firm
Pfizer Inc.
Address
235 East 42nd Street, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0235-2024
Event ID
93681
Recall initiation date
December 21, 2023
Center classification date
January 17, 2024
Code info
Lot GY2496, Exp 02/01/2025
More code info
—